Noticias
24 pacientes ahora reciben NITYR en los Estados Unidos
Después del lanzamiento de las tabletas de NITYR (nitisinona) en los Estados Unidos el año pasado, nos complace a…
Sign up for updates
Please click the button below and fill out the form to sign up to updates from our newsletter.
Sign upCycle launches COVID-19 Response Program
Given the unprecedented COVID-19 lockdown that shuts down patient access to wellbeing facilities that may seriously…
Tyrosinemia Connections: A Live Community Event
We are extremely excited to present to you a new monthly educational online community meeting series titled…
Cycle Pharmaceuticals’ Nityr® Supply Chain Update
At Cycle Pharmaceuticals, the health and safety of patients with tyrosinemia type 1 (HT-1) is our top priority. As the…